Arrowhead Pharmaceuticals (ARWR) News Today $16.84 +0.05 (+0.30%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$16.74 -0.10 (-0.59%) As of 07/7/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARWR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $43.71 Consensus Price Target from Analysts3 hours ago | americanbankingnews.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 5 at 2:37 AM | marketbeat.comState of Alaska Department of Revenue Increases Holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)June 28, 2025 | marketbeat.comARWR Arrowhead Pharmaceuticals, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comArrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of PlozasiranJune 23, 2025 | finance.yahoo.comAssenagon Asset Management S.A. Has $289,000 Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)June 20, 2025 | marketbeat.com68,346 Shares in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Bought by SG Americas Securities LLCJune 19, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Acquired by Pinion Investment Advisors LLCJune 15, 2025 | marketbeat.comRhumbline Advisers Reduces Stock Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)June 14, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded to Buy at Wall Street ZenJune 14, 2025 | marketbeat.comGAMMA Investing LLC Increases Stock Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)June 12, 2025 | marketbeat.comResearch Analysts Set Expectations for ARWR FY2026 EarningsJune 11, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Average Recommendation of "Moderate Buy" from AnalystsJune 10, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded by Wall Street Zen to Buy RatingJune 6, 2025 | marketbeat.comJim Cramer on Arrowhead Pharmaceuticals (ARWR): “It Doesn’t Make Any Money”June 5, 2025 | msn.comJim Cramer: Arrowhead Pharmaceuticals Doesn't 'Have The Horses'June 4, 2025 | benzinga.comArrowhead Pharmaceuticals, Inc. (ARWR)’s ARO-ALK7 Enters Phase 1/2a StudyJune 2, 2025 | insidermonkey.comSquarepoint Ops LLC Has $1.62 Million Stock Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 31, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Up 6.2% - Should You Buy?May 30, 2025 | marketbeat.comArrowhead Pharmaceuticals: A Reluctant Sell Rating Explained (Rating Downgrade)May 29, 2025 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and Pharma Mar SA (OtherPHMMF)May 29, 2025 | theglobeandmail.comArrowhead Pharmaceuticals to Participate in June 2025 Investor ConferencesMay 29, 2025 | businesswire.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $37.79 Million Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 27, 2025 | marketbeat.comNeo Ivy Capital Management Takes Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 26, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Acquired by Two Sigma Advisers LPMay 26, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Acquired by Two Sigma Investments LPMay 25, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded to Hold at StockNews.comMay 24, 2025 | marketbeat.comResearch Analysts Set Expectations for ARWR FY2025 EarningsMay 24, 2025 | marketbeat.comWoodline Partners LP Cuts Holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 24, 2025 | marketbeat.comMillennium Management LLC Boosts Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 24, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Receives "Buy" Rating from HC WainwrightMay 22, 2025 | marketbeat.comRafferty Asset Management LLC Cuts Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 22, 2025 | marketbeat.comSilvercrest Asset Management Group LLC Grows Stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 21, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $4.56 Million Stock Holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 21, 2025 | marketbeat.comDeutsche Bank AG Has $4.87 Million Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 21, 2025 | marketbeat.comBNP Paribas Financial Markets Acquires 32,841 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 21, 2025 | marketbeat.comTema Etfs LLC Takes $1.16 Million Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 20, 2025 | marketbeat.comDimensional Fund Advisors LP Sells 86,214 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 19, 2025 | marketbeat.comSphera Funds Management LTD. Purchases New Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 18, 2025 | marketbeat.comArrowhead Pharmaceuticals’ Earnings Call Highlights Growth and ChallengesMay 15, 2025 | tipranks.comARWR: Multiple Value Drivers for Long-Term Growth…May 15, 2025 | finance.yahoo.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Gap Up on Earnings BeatMay 15, 2025 | marketbeat.comChardan Capital Reaffirms Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)May 15, 2025 | marketbeat.comHudson Bay Capital Management LP Lowers Stock Holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 15, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Issues Quarterly Earnings ResultsMay 14, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2025 Earnings Call TranscriptMay 14, 2025 | msn.comIntegral Health Asset Management LLC Invests $5.17 Million in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 14, 2025 | marketbeat.comArrowhead Shares Rise After 2Q Earnings BeatMay 13, 2025 | marketwatch.comArrowhead Pharmaceuticals Inc (ARWR) Q2 2025 Earnings Call Highlights: Strong Financials and ...May 13, 2025 | finance.yahoo.comNorthern Trust Corp Has $27.91 Million Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)May 13, 2025 | marketbeat.com Get Arrowhead Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter. Email Address ARWR Media Mentions By Week ARWR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARWR News Sentiment▼0.590.57▲Average Medical News Sentiment ARWR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARWR Articles This Week▼16▲ARWR Articles Average Week Get Arrowhead Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Blueprint Medicines News BridgeBio Pharma News Verona Pharma PLC American Depositary Share News Roivant Sciences News Elanco Animal Health News Revolution Medicines News Legend Biotech News Grifols News TG Therapeutics News Lantheus News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARWR) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARWR Stock Alerts